CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (191,394)	$ 4,700,300
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	(87,000)	(4,884,617)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(6,500)	23,600
(Decrease) Increase in accounts payable affiliates	(332,735)	69,806
Net cash provided by (used in) operating activities	(617,629)	(90,911)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	87,000	4,884,617
Net cash provided by investing activities	87,000	4,884,617
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(530,629)	4,793,706
Cash and cash equivalents, beginning	6,622,109	22,926,529
Cash and cash equivalents, ending	6,091,480	27,720,235
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	25,000
Series Twenty [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty One [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Two [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Three [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Four [Member]
Cash flows from operating activities:
Net income (loss)	0	(10,914)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	(10,914)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	(10,914)
Cash and cash equivalents, beginning	0	402,018
Cash and cash equivalents, ending	0	391,104
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Five [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Six [Member]
Cash flows from operating activities:
Net income (loss)	(15,665)	(18,860)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	(15,665)	(18,860)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(15,665)	(18,860)
Cash and cash equivalents, beginning	576,004	554,439
Cash and cash equivalents, ending	560,339	535,579
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Seven [Member]
Cash flows from operating activities:
Net income (loss)	0	9,555
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	9,555
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	9,555
Cash and cash equivalents, beginning	0	6,500,234
Cash and cash equivalents, ending	0	6,509,789
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Eight [Member]
Cash flows from operating activities:
Net income (loss)	0	(10,673)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	(10,673)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	(10,673)
Cash and cash equivalents, beginning	0	690,605
Cash and cash equivalents, ending	0	679,932
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Nine [Member]
Cash flows from operating activities:
Net income (loss)	(7,081)	(13,024)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	(9,500)	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	6,854	7,260
Net cash provided by (used in) operating activities	(9,727)	(5,764)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	9,500	0
Net cash provided by investing activities	9,500	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(227)	(5,764)
Cash and cash equivalents, beginning	157,446	196,944
Cash and cash equivalents, ending	157,219	191,180
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty One [Member]
Cash flows from operating activities:
Net income (loss)	0	644,052
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(587,469)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	8,000
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	64,583
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	587,469
Net cash provided by investing activities	0	587,469
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	652,052
Cash and cash equivalents, beginning	0	1,953,570
Cash and cash equivalents, ending	0	2,605,622
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	25,000
Series Thirty Two [Member]
Cash flows from operating activities:
Net income (loss)	(26,327)	(13,770)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	15,132	19,794
Net cash provided by (used in) operating activities	(11,195)	6,024
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(11,195)	6,024
Cash and cash equivalents, beginning	193,203	272,226
Cash and cash equivalents, ending	182,008	278,250
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Three [Member]
Cash flows from operating activities:
Net income (loss)	(18,953)	(1,425)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	13,318
Net cash provided by (used in) operating activities	(18,953)	11,893
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(18,953)	11,893
Cash and cash equivalents, beginning	561,941	236,612
Cash and cash equivalents, ending	542,988	248,505
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Four [Member]
Cash flows from operating activities:
Net income (loss)	(16,961)	(14,641)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	6,727	12,365
Net cash provided by (used in) operating activities	(10,234)	(2,276)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(10,234)	(2,276)
Cash and cash equivalents, beginning	148,344	178,285
Cash and cash equivalents, ending	138,110	176,009
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Five [Member]
Cash flows from operating activities:
Net income (loss)	0	2,681
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	2,681
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	2,681
Cash and cash equivalents, beginning	0	4,395,774
Cash and cash equivalents, ending	0	4,398,455
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Six [Member]
Cash flows from operating activities:
Net income (loss)	0	475,620
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(476,325)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	100
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	(605)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	476,325
Net cash provided by investing activities	0	476,325
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	475,720
Cash and cash equivalents, beginning	0	2,541,359
Cash and cash equivalents, ending	0	3,017,079
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Seven [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Eight [Member]
Cash flows from operating activities:
Net income (loss)	0	1,445,265
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(1,463,974)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	14,000
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	(4,709)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	1,463,974
Net cash provided by investing activities	0	1,463,974
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	1,459,265
Cash and cash equivalents, beginning	0	1,499,106
Cash and cash equivalents, ending	0	2,958,371
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Nine [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty [Member]
Cash flows from operating activities:
Net income (loss)	0	(18,106)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	(9,500)
(Decrease) Increase in accounts payable affiliates	0	20,870
Net cash provided by (used in) operating activities	0	(6,736)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	(6,736)
Cash and cash equivalents, beginning	0	193,344
Cash and cash equivalents, ending	0	186,608
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty One [Member]
Cash flows from operating activities:
Net income (loss)	(34,776)	20,620
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	28,521	34,077
Net cash provided by (used in) operating activities	(6,255)	54,697
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(6,255)	54,697
Cash and cash equivalents, beginning	352,239	246,214
Cash and cash equivalents, ending	345,984	300,911
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Two [Member]
Cash flows from operating activities:
Net income (loss)	(29,100)	(18,145)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash provided by (used in) operating activities	(29,100)	(18,145)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(29,100)	(18,145)
Cash and cash equivalents, beginning	1,607,893	1,300,483
Cash and cash equivalents, ending	1,578,793	1,282,338
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Three [Member]
Cash flows from operating activities:
Net income (loss)	(18,836)	1,031,419
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	(9,000)	(1,060,582)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	3,000	4,950
(Decrease) Increase in accounts payable affiliates	0	31,111
Net cash provided by (used in) operating activities	(24,836)	6,898
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	9,000	1,060,582
Net cash provided by investing activities	9,000	1,060,582
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(15,836)	1,067,480
Cash and cash equivalents, beginning	1,416,291	414,540
Cash and cash equivalents, ending	1,400,455	1,482,020
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Four [Member]
Cash flows from operating activities:
Net income (loss)	(34,596)	1,244,211
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	(1,296,267)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(4,000)	6,050
(Decrease) Increase in accounts payable affiliates	30,315	(180,932)
Net cash provided by (used in) operating activities	(8,281)	(226,938)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	1,296,267
Net cash provided by investing activities	0	1,296,267
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(8,281)	1,069,329
Cash and cash equivalents, beginning	321,693	113,020
Cash and cash equivalents, ending	313,412	1,182,349
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Five [Member]
Cash flows from operating activities:
Net income (loss)	(22,959)	(30,784)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(12,000)	0
(Decrease) Increase in accounts payable affiliates	(468,773)	59,644
Net cash provided by (used in) operating activities	(503,732)	28,860
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(503,732)	28,860
Cash and cash equivalents, beginning	859,371	916,581
Cash and cash equivalents, ending	355,639	945,441
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Six [Member]
Cash flows from operating activities:
Net income (loss)	33,860	(22,781)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Gain on disposition of Operating Partnerships	(68,500)	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	6,500	0
(Decrease) Increase in accounts payable affiliates	48,489	52,299
Net cash provided by (used in) operating activities	20,349	29,518
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	68,500	0
Net cash provided by investing activities	68,500	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	88,849	29,518
Cash and cash equivalents, beginning	427,684	321,175
Cash and cash equivalents, ending	516,533	350,693
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	$ 0	$ 0